| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |